Literature DB >> 3511440

Role of glucose in the regulation of endogenous glucose production in the human newborn.

S C Kalhan, A Oliven, K C King, C Lucero.   

Abstract

The role of plasma glucose concentration in the regulation of endogenous glucose production in the human newborn was examined by infusing glucose at 2.6-4.6 mg/kg . min as a continuous infusion to eight normal term appropriate for gestational age infants, five preterm, and six small for gestational age infants. All infants were healthy, had no overt clinical problems and were studied 6 h after their last feed. Glucose production rates were measured during the basal state and during glucose infusion by tracer dilution using [6,6(2)H2]glucose. The rate of glucose production during the basal state was similar in preterm and term appropriate for gestational age infants (appropriate for gestational age 3.53 +/- 0.32, preterm 3.49 +/- 0.38 mg/kg . min, mean +/- SD), while it was higher in the small for gestational age infants (4.25 +/- 0.98, p less than 0.03) as compared with appropriate for gestational age. During glucose infusion, the peak glucose concentration was related to the rate of glucose infusion. The endogenous glucose production rates during glucose infusion were variable in the three groups. However, a negative correlation between peak glucose concentration and endogenous glucose production rate was observed (r = 0.59, p = 0.006). The insulin response to glucose infusion was comparable in all infants. In addition, three small gestational age and one preterm infants, who had become hypoglycemic in the immediate newborn period, were studied while they were receiving parenteral glucose and their plasma glucose had stabilized at 55.5 +/- 10.25 mg/dl. Tracer kinetic studies showed persistence of endogenous glucose production in these infants even though they were receiving high rates of exogenous glucose infusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511440     DOI: 10.1203/00006450-198601000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  17 in total

Review 1.  Hypoglycaemia of the newborn: a review.

Authors:  A F Williams
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Neonatal hypoglycaemia in Nepal 1. Prevalence and risk factors.

Authors:  D K Pal; D S Manandhar; S Rajbhandari; J M Land; N Patel; A M de L Costello
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

Review 3.  Glucose metabolism in the mother and the newborn infant.

Authors:  S C Kalhan
Journal:  Indian J Pediatr       Date:  1991 Jan-Feb       Impact factor: 1.967

4.  N-carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy.

Authors:  Sandra K Heibel; Nicholas Ah Mew; Ljubica Caldovic; Yevgeny Daikhin; Marc Yudkoff; Mendel Tuchman
Journal:  Hum Mutat       Date:  2011-09-09       Impact factor: 4.878

5.  Blood glucose controller for neonatal intensive care: virtual trials development and first clinical trials.

Authors:  Aaron Le Compte; J Geoffrey Chase; Adrienne Lynn; Chris Hann; Geoffrey Shaw; Xing-Wei Wong; Jessica Lin
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

Review 6.  Prevention and management of neonatal hypoglycaemia.

Authors:  A Mehta
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

7.  Role of placental insufficiency and intrauterine growth restriction on the activation of fetal hepatic glucose production.

Authors:  Stephanie R Wesolowski; William W Hay
Journal:  Mol Cell Endocrinol       Date:  2015-12-23       Impact factor: 4.102

8.  Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns.

Authors:  D E Hertz; C A Karn; Y M Liu; E A Liechty; S C Denne
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Inositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes.

Authors:  Laura D Brown; Alex Cheung; Jeri E F Harwood; Frederick C Battaglia
Journal:  J Nutr       Date:  2009-06-03       Impact factor: 4.798

10.  The role of pancreatic insulin secretion in neonatal glucoregulation. II. Infants with disordered blood glucose homoeostasis.

Authors:  J M Hawdon; A Aynsley-Green; K Bartlett; M P Ward Platt
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.